PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2015-02-17
What PERSPECTIVE THERAPEUTICS, INC. reported in its quarterly report filed 2015-02-17 (fiscal Q2 2015): 27 published measures, 73 facts as tagged in accession 0001144204-15-010049.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-02-17
- Fiscal period
- fiscal Q2 2015
- Accession
- 0001144204-15-010049 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 24,585,098 | USD | |
| At 2014-06-30 | 26,549,255 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 2,057,186 | USD | |
| At 2014-06-30 | 2,593,487 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 22,527,912 | USD | |
| At 2014-06-30 | 23,955,768 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,336,853 | USD | |
| At 2014-06-30 | 7,680,073 | USD | |
| At 2013-12-31 | 4,414,572 | USD | |
| At 2013-06-30 | 2,899,927 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -906,954 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -1,692,816 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -926,972 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -2,197,878 | USD | 184 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 48,657 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 14,419 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -59,743,272 | USD | |
| At 2014-06-30 | -58,050,456 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 761,425 | USD | |
| At 2014-06-30 | 1,017,915 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 42,907 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 51,786 | USD | 184 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -1,020,314 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -2,181,420 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -1,044,367 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -2,278,886 | USD | 184 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 12,825,097 | USD | |
| At 2014-06-30 | 19,214,900 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 3,451 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 86 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 827 | USD | 184 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 941,892 | USD | |
| At 2014-06-30 | 1,153,927 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 797,381 | USD | |
| At 2014-06-30 | 913,049 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 982,350 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 2,088,654 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 1,010,461 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 2,167,672 | USD | 184 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 411,420 | USD | |
| At 2014-06-30 | 359,737 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -37,964 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -92,766 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -33,906 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -111,214 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 140,627 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 317,237 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 170,030 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 317,020 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 54,883,445 | shares | |
| At 2014-06-30 | 54,701,708 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 82,224,632 | USD | |
| At 2014-06-30 | 81,959,853 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 250,903 | USD | |
| At 2014-06-30 | 264,076 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 221,167 | USD | |
| At 2014-06-30 | 206,047 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -909,612 | USD | 92 |
| 2014-07-01 to 2014-12-31 | -1,698,132 | USD | 184 |
| 2013-10-01 to 2013-12-31 | -929,630 | USD | 92 |
| 2013-07-01 to 2013-12-31 | -2,929,572 | USD | 184 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 537,940 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 1,113,891 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 513,964 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 1,165,000 | USD | 184 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 113,360 | USD | 92 |
| 2014-07-01 to 2014-12-31 | 488,604 | USD | 184 |
| 2013-10-01 to 2013-12-31 | 117,395 | USD | 92 |
| 2013-07-01 to 2013-12-31 | 81,008 | USD | 184 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | -124,275 | USD | 184 |
| 2013-07-01 to 2013-12-31 | -26,641 | USD | 184 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-12-31 | 51,683 | USD | 184 |
| 2013-07-01 to 2013-12-31 | 20,762 | USD | 184 |
Inspect the source
- Entity
- PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
- Captured
- 2026-09-19T15:00:29.793Z
- SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))